The LIFE Offering continues to be conducted on a non-brokered basis at a price of $0.10 per unit of the Company (each, a "Unit"), for the issuance of up to an additional 2,606,900 Units pursuant to the upsizing, bringing the maximum number of Units issuable under the LIFE Offering to 26,267,500 Units if fully subscribed.
Each Unit will consist of one immediately free trading common share in the capital of the Company and one common share purchase warrant (each, a "Warrant"). Each Warrant will entitle the holder to purchase one common share of the Company at a price of C$0.20 per common share for a period of 36 months following the Closing Date, commencing on the date that is 60 days from the Closing Date, subject to acceleration in certain circumstances.
The net proceeds from the sale of the Units will be used for ongoing project and administrative expenditures including permit renewal relating to the Company's Shymanivske Project and general corporate purposes and working capital as set out in the offering document.
The completion of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals, including the approval of the Toronto Stock Exchange, and closing for minimum gross proceeds of approximately US$1,200,000 (C$1,659,000).
In connection with the upsizing of the LIFE Offering, the Company has filed an amended and restated offering document dated April 15, 2026 (the "Amended and Restated Offering Document") pursuant to and in accordance with the "listed issuer financing exemption" from the prospectus requirement available under section 5A of National Instrument 45-106, Prospectus Exemptions, as amended by Coordinated Blanket ...
